D.E. Shaw & Co’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
89,475
+10,200
| +13% | +$14.6K | ﹤0.01% | 2873 |
|
|
2025
Q1 | $127K | Buy |
79,275
+2,796
| +4% | +$4.47K | ﹤0.01% | 2825 |
|
|
2024
Q4 | $275K | Sell |
76,479
-42,413
| -36% | -$153K | ﹤0.01% | 2632 |
|
|
2024
Q3 | $678K | Sell |
118,892
-237,320
| -67% | -$1.35M | ﹤0.01% | 2338 |
|
|
2024
Q2 | $1.65M | Sell |
356,212
-140,331
| -28% | -$648K | ﹤0.01% | 1932 |
|
|
2024
Q1 | $4.06M | Buy |
496,543
+252,905
| +104% | +$2.07M | ﹤0.01% | 1381 |
|
|
2023
Q4 | $1.38M | Sell |
243,638
-190,472
| -44% | -$1.08M | ﹤0.01% | 1911 |
|
|
2023
Q3 | $807K | Sell |
434,110
-85,069
| -16% | -$158K | ﹤0.01% | 2123 |
|
|
2023
Q2 | $1.43M | Buy |
519,179
+325,018
| +167% | +$894K | ﹤0.01% | 1919 |
|
|
2023
Q1 | $610K | Buy |
194,161
+108,200
| +126% | +$340K | ﹤0.01% | 2430 |
|
|
2022
Q4 | $507K | Sell |
85,961
-44,121
| -34% | -$260K | ﹤0.01% | 2707 |
|
|
2022
Q3 | $1.14M | Buy |
130,082
+51,294
| +65% | +$450K | ﹤0.01% | 2477 |
|
|
2022
Q2 | $594K | Buy |
+78,788
| New | +$594K | ﹤0.01% | 2970 |
|
|
2022
Q1 | – | Sell |
-25,735
| Closed | -$829K | – | 4269 |
|
|
2021
Q4 | $829K | Buy |
25,735
+15,852
| +160% | +$511K | ﹤0.01% | 2851 |
|
|
2021
Q3 | $442K | Sell |
9,883
-6,649
| -40% | -$297K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $626K | Buy |
16,532
+11,102
| +204% | +$420K | ﹤0.01% | 2785 |
|
|
2021
Q1 | $201K | Sell |
5,430
-7,144
| -57% | -$264K | ﹤0.01% | 2791 |
|
|
2020
Q4 | $417K | Buy |
+12,574
| New | +$417K | ﹤0.01% | 2348 |
|